Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Kansas Medical Center
Eli Lilly and Company
City of Hope Medical Center
NantCell, Inc.
City of Hope Medical Center
Tempus AI
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Incyte Corporation
Incyte Corporation
Sichuan Enray Pharmaceutical Sciences Company
Trishula Therapeutics, Inc.
Institut Bergonié
NRG Oncology
Hoffmann-La Roche
Elevation Oncology
Intensity Therapeutics, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI)
NantCell, Inc.
VA Office of Research and Development
Weill Medical College of Cornell University
NextCure, Inc.
Massachusetts General Hospital
Rutgers, The State University of New Jersey
pharmaand GmbH
Revolution Medicines, Inc.
Dana-Farber Cancer Institute
National Institutes of Health Clinical Center (CC)
Washington University School of Medicine
Montefiore Medical Center
OBI Pharma, Inc
Pfizer
National Institutes of Health Clinical Center (CC)
Incyte Corporation
Hackensack Meridian Health
Wake Forest University Health Sciences
Wake Forest University Health Sciences
Seagen Inc.
Institut Bergonié
University of Chicago
National Institutes of Health Clinical Center (CC)
University of Texas Southwestern Medical Center
Pfizer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Icahn School of Medicine at Mount Sinai
Pharmacyclics LLC.
Washington University School of Medicine
Stanford University